Lioresal and Dark tongue - a phase IV clinical study of FDA data
We study 20,008 people who take Lioresal or have Dark tongue. No report of Dark tongue is found in people who take Lioresal.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Lioresal?
Lioresal has active ingredients of baclofen. It is often used in multiple sclerosis. eHealthMe is studying from 19,861 Lioresal users for its effectiveness, alternative drugs and more.
What is Dark Tongue?
Dark tongue: no further information found.
Do you take Lioresal and have Dark tongue?Check whether Dark tongue is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Dark tongue and when was it recovered:
Expand to all the drugs that have ingredients of baclofen:
Alternative drugs to, pros and cons of Lioresal:
- Lioresal (19,861 reports)
Dark tongue treatments and more:
- Dark tongue (147 reports)
COVID vaccines that are related to Dark tongue:
- Dark tongue in Moderna COVID Vaccine
- Dark tongue in Pfizer BioNTech Covid Vaccine
- Dark tongue in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Dark tongue:
All the conditions that are associated with Dark tongue:
How the study uses the data?
The study uses data from the FDA. It is based on baclofen (the active ingredients of Lioresal) and Lioresal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Klonopin and Cholecystitis Infective - now
- Fentanyl-100 and Haematemesis - now
- Temozolomide and Carboplatin drug interaction - 3 seconds ago
- Jock Itch and Dermal Cyst - 4 seconds ago
- Calcium D-Pantothenate and Pneumonia - 6 seconds ago
- Soma and Drug Administration Error - 8 seconds ago
- Naproxen and Emsam drug interaction - 13 seconds ago
- Zemplar and Ventricular Fibrillation - 15 seconds ago
- Tylenol and Jock Itch - 15 seconds ago
- Lisinopril and High Density Lipoprotein - 18 seconds ago